New study tracks real-world use of zanubrutinib for rare blood cancer
NCT ID NCT05640102
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 30 times
Summary
This study is observing people with Waldenström macroglobulinemia (a rare blood cancer) who are taking the drug zanubrutinib. Researchers want to see how well the drug works and how safe it is, especially in people with certain genetic mutations and from racial and ethnic minority groups. About 111 participants will be followed over time to collect this information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WALDENSTROM MACROGLOBULINEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
City of Hope National Medical Center
RECRUITINGDuarte, California, 91010-3012, United States
-
Clearview Cancer Institute
RECRUITINGHuntsville, Alabama, 35805-2606, United States
-
Comprehensive Cancer Centers of Nevada
RECRUITINGLas Vegas, Nevada, 89169-3321, United States
-
Eisenhower Medical Center, Lucy Curci Cancer Center
RECRUITINGRancho Mirage, California, 92270-3221, United States
-
Hattiesburg Hematology and Oncology Clinic
RECRUITINGHattiesburg, Mississippi, 39401-7233, United States
-
Los Angeles Cancer Network (Lacn)
RECRUITINGGlendale, California, 91204-3640, United States
-
Pan American Oncology Trials, Llc
RECRUITINGRio Piedras, 00935, Puerto Rico
-
South Alabama Medical Science Foundation Mitchell Cancer Institute
RECRUITINGMobile, Alabama, 36604-1405, United States
Conditions
Explore the condition pages connected to this study.